Spinal fusion with recombinant human growth and differentiation factor-5 combined with a mineralized collagen matrix

Anatomical Record

Volumn 263, Issue 4, 2001, Pages 388-395

  Spiro, Robert C ^a,b   Thompson, Andrea Y ^a   Poser, James W ^a  

^a Orquest Inc   (United States)

^b FIBROGEN INC   (United States)

Author keywords

Autograft; Bone graft; Bone morphogenetic protein; Growth differentiation factor 5; Mineralized collagen; Osteoconductive matrix; Osteoinduction; Posterolateral spine fusion

Indexed keywords

BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; GROWTH DIFFERENTIATION FACTOR 5;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BONE GRAFT; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPINE FUSION; SPINE RADIOGRAPHY; SPINE SURGERY; TRABECULAR BONE;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; CATTLE; COLLAGEN; COMPRESSIVE STRENGTH; FRACTURE HEALING; GROWTH SUBSTANCES; LUMBAR VERTEBRAE; MALE; MATERIALS TESTING; OSTEOGENESIS; RABBITS; RECOMBINANT PROTEINS; SPINAL FUSION;

ORYCTOLAGUS CUNICULUS;

EID: 0035425489     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ar.1119     Document Type: Article

References (25)

1. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate
2. An experimental lumbar intertransverse process spinal fusion model
3. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species
4. Cartilage-derived morphogenetic proteins
5. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions
6. Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine
7. Extracellular matrix modulation of rhGDF-5-induced cellular differentiation
8. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: A comparison between two bone graft materials: rhBMP-2 and autograft
9. Role of bone substitutes
10. Cloning and expression of recombinant human growth/differentiation factor 5
11. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: Important lessons learned regarding dose, carrier, and safety
12. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2
13. Evaluation of bone-grafting materials in a new canine segmental spinal fusion model
14. Evaluation of human bone morphogenetic protein 2 in a canine model
15. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5
16. Mutations in CDMP1 cause autosomal dominant brachydactyly type C
17. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements
18. Evaluation of a new mineralized collagen bone grafting matrix in a long bone critical defect model
19. Inductive activity of recombinant human growth and differentiation factor-5
20. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily
21. Use of a collagen-hydroxyapatite matrix in spinal fusion
22. Vascularization of the fusion mass in a posterolateral intertransverse process fusion
23. Growth/differentiation factor-5 induces angiogenesis in vivo
24. Morbidity at bone graft donor sites
25. Fibrillar collagen-biphasic calcium phosphate composite as a bone graft substitute for spinal fusion